Acute myelomonoblastic leukemia in a patient with multiple myeloma.
A 40-year-old man who developed acute myelomonoblastic leukemia (M4) after 7 years of treatment for multiple myeloma with the alkylating agent melphalan and steroids is presented. Leukemia was treated with courses of adriblastin, cytosine arabinoside, and thioguanin (DAT protocol), with a 8 months' survival.
Colović
M
M
Jovanović
V
V
Ristić
M
M
D000328:Adult; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008558:Melphalan / Q000009:adverse effects; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology
D008558:Melphalan